Crypto Daily Scoop

INJ, PEARL, ZEC surge as traders return to altcoins

Injective (INJ), PEARL, and Zcash (ZEC) are seeing a surge as crypto traders pivot back toward altcoins, riding a wave of renewed market energy.

cryptonews.com

This movement shows investors are seeking opportunities across various crypto sectors, looking past Bitcoin and major altcoins. Injective provides access to on-chain finance, Pearl Research connects to decentralized computing, and Zcash maintains interest due to its privacy features.

Injective (INJ) focuses on decentralized finance and on-chain trading infrastructure, utilizing a proof-of-stake network where holders can delegate tokens for staking rewards. Institutional interest has also surfaced via investment products linked to its native token.

Pearl (PEARL) has built its story around AI and blockchain infrastructure, featuring a network designed to support decentralized computing via its Proof-of-Useful-Work model. Meanwhile, Zcash (ZEC) attracts attention as a privacy-focused crypto, offering shielded transaction features to protect details.

The altcoin recovery has also brought Bitcoin scaling projects into focus, especially those aiming to broaden Bitcoin's use beyond just a store of value. Bitcoin Hyper is developing this vision as a Bitcoin Layer 2, engineered to support faster transactions and smart-contract capabilities using the Solana Virtual Machine.

Bitcoin Hyper’s HYPER token is currently available in a presale at $0.0136, with the sale set to conclude on November 26, 2026. The project's official site confirms the sale has already amassed over $33.2 million.

This presale is entering its final weeks, setting a stated deadline before the planned token launch. Furthermore, Bitcoin Hyper offers a 35% annual percentage yield for stakers during the presale, a rate significantly higher than the variable rewards from Injective crypto staking.

Comparing fundraising efforts, Bitcoin Hyper's $33.2 million total surpasses the $25 million seed round secured by Zcash Open Development Lab. Injective has raised $40 million in a private token sale, while Pearl Research Labs has reported a larger equity funding total.

Why it matters

This rally signals renewed investor appetite beyond Bitcoin, showing interest in specific niches like DeFi, AI infrastructure, and privacy. Traders should watch how these distinct altcoin narratives compete for capital as the Bitcoin Hyper presale nears its deadline.

Earlier coverage

#bitcoin#ethereum#defi

Read the original ↗

Related coverage

Next on the wire

  1. Bitcoin weakness erases September's bullish signal

  2. Bitcoin dips, Nvidia falls, ETF outflows hit $299.9 million

  3. Canaan may sell Bitcoin for buybacks as rig revenue drops 96%

  4. Stablecoin Drain, ETF Outflows Slash Bitcoin Supply $14.2 Billion

  5. Short-Term Holders Move $3.6 Billion BTC to Exchanges At Loss